Similar Papers

Paper Title
Journal
Date
Author
Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients
V.J Quagliarello ... R.I Horwitz
The Lancet | VOL. 345
V.J Quagliarello, et. al.V.J Quagliarello ... R.I Horwitz
01 Mar 1995
Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management.
Sm Barry ... Ma Johnson
HIV medicine | VOL. 2
Sm Barry, et. al.Sm Barry ... Ma Johnson
01 Apr 2001
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection
Gerrit J Weverling ... Peter Reiss
The Lancet | VOL. 353
Gerrit J Weverling, et. al.Gerrit J Weverling ... Peter Reiss
01 Apr 1999
Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy.
Chien-Ching Hung ... Wang-Hwei Sheng
AIDS (London, England) | VOL. 16
Chien-Ching Hung, et. al.Chien-Ching Hung ... Wang-Hwei Sheng
01 Mar 2002
View more papers

More From: AIDS

Paper Title
Journal
Date
Author
Hepcidin modifies the relationship between anemia, erythrocyte indices, and neurocognitive performance in virally suppressed people with HIV
Azin Tavasoli ... Scott L Letendre
AIDS | VOL. -
Azin Tavasoli, et. al.Azin Tavasoli ... Scott L Letendre
07 Jan 2025
Neurodevelopmental outcomes in children exposed in utero to dolutegravir- or efavirenz-based ART
Adam R Cassidy ... Shahin Lockman
AIDS | VOL. -
Adam R Cassidy, et. al.Adam R Cassidy ... Shahin Lockman
06 Jan 2025
Contribution of HIV transmission bursts to future HIV infections, United States
Rachael M Billock ... Alexandra M Oster
AIDS | VOL. -
Rachael M Billock, et. al.Rachael M Billock ... Alexandra M Oster
24 Dec 2024
Dolutegravir regimens have transformed treatment but ongoing drug resistance research is required to maintain success
Gert U Van Zyl ... Catherine Orrell
AIDS | VOL. -
Gert U Van Zyl, et. al.Gert U Van Zyl ... Catherine Orrell
23 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.